메뉴 건너뛰기




Volumn 29, Issue 3, 2013, Pages 951-959

Phase I clinical trial of a peptide vaccine combined with tegafur-uracil plus leucovorin for treatment of advanced or recurrent colorectal cancer

Author keywords

Chemotherapy; Clinical trial; Colorectal cancer; Immunotherapy; Peptide vaccine

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; IRINOTECAN; MONTANIDE ISA 51; OXALIPLATIN; PEPTIDE VACCINE; RAD18 PROTEIN VACCINE; TOMM34 VACCINE; UFT; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1 VACCINE; VASCULOTROPIN RECEPTOR 2 VACCINE;

EID: 84872782184     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2231     Document Type: Article
Times cited : (20)

References (25)
  • 1
    • 39049153587 scopus 로고    scopus 로고
    • Identification of TOMM34, which shows elevated expression in the majority of human colon cancers, as a novel drug target
    • Shimokawa T, Matsushima S, Tsunoda T, Tahara H, Nakamura Y and Furukawa Y: Identification of TOMM34, which shows elevated expression in the majority of human colon cancers, as a novel drug target. Int J Oncol 29: 381-386, 2006.
    • (2006) Int J Oncol , vol.29 , pp. 381-386
    • Shimokawa, T.1    Matsushima, S.2    Tsunoda, T.3    Tahara, H.4    Nakamura, Y.5    Furukawa, Y.6
  • 2
    • 0037071875 scopus 로고    scopus 로고
    • Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas
    • DOI 10.1038/sj.onc.1205518
    • Lin YM, Furukawa Y, Tsunoda T, Yue CT, Yang KC and Nakamura Y: Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene 21: 4120-4128, 2002. (Pubitemid 34712879)
    • (2002) Oncogene , vol.21 , Issue.26 , pp. 4120-4128
    • Lin, Y.-M.1    Furukawa, Y.2    Tsunoda, T.3    Yue, C.-T.4    Yang, K.-C.5    Nakamura, Y.6
  • 3
  • 4
    • 0032549799 scopus 로고    scopus 로고
    • Neuropilin-1 is expressed by endothelial and tumor cells as an isoform- specific receptor for vascular endothelial growth factor
    • DOI 10.1016/S0092-8674(00)81402-6
    • Soker S, Takashima S, Miao HQ, Neufield G and Klagsbrun M: Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92: 735-745, 1998. (Pubitemid 28155313)
    • (1998) Cell , vol.92 , Issue.6 , pp. 735-745
    • Soker, S.1    Takashima, S.2    Miao, H.Q.3    Neufeld, G.4    Klagsbrun, M.5
  • 7
    • 19644378474 scopus 로고    scopus 로고
    • Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2
    • DOI 10.1158/0008-5472.CAN-04-3759
    • Wada S, Tsunoda T, Baba T, Primus FJ, Kuwano H, Shibuya M and Tahara H: Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2. Cancer Res 65: 4939-4946, 2005 (Pubitemid 40740834)
    • (2005) Cancer Research , vol.65 , Issue.11 , pp. 4939-4946
    • Wada, S.1    Tsunoda, T.2    Baba, T.3    Primus, F.J.4    Kuwano, H.5    Shibuya, M.6    Tahara, H.7
  • 9
    • 0036727089 scopus 로고    scopus 로고
    • Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer
    • DOI 10.1200/JCO.2002.10.129
    • Carmichael J, Popiela T, Radstone D, Falk S, Borner M, Oza A, Skovsgaard T, Munier S and Martin C: Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20: 3617-3627, 2002. (Pubitemid 34983221)
    • (2002) Journal of Clinical Oncology , vol.20 , Issue.17 , pp. 3617-3627
    • Carmichael, J.1    Popiela, T.2    Radstone, D.3    Falk, S.4    Borner, M.5    Oza, A.6    Skovsgaard, T.7    Munier, S.8    Martin, C.9
  • 12
    • 33744815600 scopus 로고    scopus 로고
    • Clinical and immunologic responses to active specific cancer vaccines in human colorectal cancer
    • DOI 10.1158/1078-0432.CCR-05-2788
    • Nagorsen D and Thiel E Clinical and immunologic responses to active specific cancer vaccines in human colorectal cancer. Clin Cancer Res 12: 3064-3069, 2006. (Pubitemid 43837352)
    • (2006) Clinical Cancer Research , vol.12 , Issue.10 , pp. 3064-3069
    • Nagorsen, D.1    Thiel, E.2
  • 13
    • 4644324025 scopus 로고    scopus 로고
    • Cancer immunotherapy: Moving beyond current vaccines
    • DOI 10.1038/nm1100
    • Rosenberg SA, Yang JC and Restifo NP: Cancer immunotherapy: moving beyond current vaccines. Nat Med 10: 909-915, 2004 (Pubitemid 39273730)
    • (2004) Nature Medicine , vol.10 , Issue.9 , pp. 909-915
    • Rosenberg, S.A.1    Yang, J.C.2    Restifo, N.P.3
  • 14
    • 67650648498 scopus 로고    scopus 로고
    • Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer
    • Kono K, Mizukami Y, Daigo Y, Takano A, Masuda K, Yoshida K, Tsunoda T, Kawaguchi Y, Nakamura Y and Fujii H: Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer. Cancer Sci 100: 1502-1509, 2009
    • (2009) Cancer Sci , vol.100 , pp. 1502-1509
    • Kono, K.1    Mizukami, Y.2    Daigo, Y.3    Takano, A.4    Masuda, K.5    Yoshida, K.6    Tsunoda, T.7    Kawaguchi, Y.8    Nakamura, Y.9    Fujii, H.10
  • 15
    • 33644789357 scopus 로고    scopus 로고
    • Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients
    • DOI 10.1200/JCO.2005.12.147
    • Correale P, Cusi MG, Tsang KY, Del Vecchio MT, Marsili S, Placa ML, Intrivici C, Aquino A, Micheli L, Nencini C, Ferrari F, Giorgi G, Bonmassar E and Francini G: Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients. J Clin Oncol 23: 8950-8958, 2005 (Pubitemid 46211480)
    • (2005) Journal of Clinical Oncology , vol.23 , Issue.35 , pp. 8950-8958
    • Correale, P.1    Cusi, M.G.2    Tsang, K.Y.3    Del Vecchio, M.T.4    Marsili, S.5    La Placa, M.6    Intrivici, C.7    Aquino, A.8    Micheli, L.9    Nencini, C.10    Ferrari, F.11    Giorgi, G.12    Bonmassar, E.13    Francini, G.14
  • 17
    • 21844463061 scopus 로고    scopus 로고
    • Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cells
    • Dauer M, Herten J, Bauer C, Renner F, Schad K, Schnurr M, Endres S and Eigler A: Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cells. J Immunother 28: 332-342, 2005 (Pubitemid 40962326)
    • (2005) Journal of Immunotherapy , vol.28 , Issue.4 , pp. 332-342
    • Dauer, M.1    Herten, J.2    Bauer, C.3    Renner, F.4    Schad, K.5    Schnurr, M.6    Endres, S.7    Eigler, A.8
  • 18
    • 23244464772 scopus 로고    scopus 로고
    • Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro
    • Correale P, Cusi MG, Del Vecchio MT, Aquino A, Prete SP, Tsang KY, Micheli L, Nencini C, La Placa M, Montagnani F, Terrosi C, Caraglia M, Formica V, Giorgi G, Bonmassar E and Francini G: Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxali-platin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro. J Immunol 175: 820-828, 2005 (Pubitemid 41094964)
    • (2005) Journal of Immunology , vol.175 , Issue.2 , pp. 820-828
    • Correale, P.1    Cusi, M.G.2    Del Vecchio, M.T.3    Aquino, A.4    Prete, S.5    Tsang, K.Y.6    Micheli, L.7    Nencini, C.8    La Placa, M.9    Montagnani, F.10    Terrosi, C.11    Caraglia, M.12    Formica, V.13    Giorgi, G.14    Bonmassar, E.15    Francini, G.16
  • 19
    • 34249879033 scopus 로고    scopus 로고
    • Immunological evaluation of personalized peptide vaccination in combination with a 5-fluorouracil derivative (TS-1) for advanced gastric or colorectal carcinoma patients
    • DOI 10.1111/j.1349-7006.2007.00498.x
    • Sato Y, Fujiwara T, Mine T, Shomura H, Homma S, Maeda Y, Tokunaga N, Ikeda Y, Ishihara Y, Yamada A, Tanaka N, Itoh K, Harada M and Todo S: Immunological evaluation of personalized peptide vaccination in combination with a 5-fluorouracil derivative (TS-1) for advanced gastric or colorectal carcinoma patients. Cancer Sci 98: 1113-1119, 2007 (Pubitemid 46865399)
    • (2007) Cancer Science , vol.98 , Issue.7 , pp. 1113-1119
    • Sato, Y.1    Fujiwara, T.2    Mine, T.3    Shomura, H.4    Homma, S.5    Maeda, Y.6    Tokunaga, N.7    Ikeda, Y.8    Ishihara, Y.9    Yamada, A.10    Tanaka, N.11    Itoh, K.12    Harada, M.13    Todo, S.14
  • 21
    • 23844514389 scopus 로고    scopus 로고
    • Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer
    • DOI 10.1158/1078-0432.CCR-05-0018
    • Weihrauch MR, Ansén S, Jurkiewicz E, Geisen C, Xia Z, Anderson KS, Gracien E, Schmidt M, Wittig B, Diehl V, Wolf J, Bohlen H and Nadler LM: Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer. Clin Cancer Res 11: 5993-6001, 2005. (Pubitemid 41170331)
    • (2005) Clinical Cancer Research , vol.11 , Issue.16 , pp. 5993-6001
    • Weihrauch, M.R.1    Arisen, S.2    Jurkiewicz, E.3    Geisen, C.4    Xia, Z.5    Anderson, K.S.6    Gracien, E.7    Schmidt, M.8    Wittig, B.9    Diehl, V.10    Wolf, J.11    Bohlen, H.12    Nadler, L.M.13
  • 23
    • 0029623185 scopus 로고
    • Restoration of interleukin-2 production in tumor-bearing rats through reducing tumor-derived transforming growth factor β by treatment with bleomycin
    • DOI 10.1007/s002620050239
    • Yuan L, Kuramitsu Y, Li Y, Kobayashi M and Hosokawa M: Restoration of interleukin-2 production in tumor-bearing rats through reducing tumor-derived transforming growth factor beta by treatment with bleomycin. Cancer Immunol Immunother 41: 355-362, 1995 (Pubitemid 26041719)
    • (1995) Cancer Immunology Immunotherapy , vol.41 , Issue.6 , pp. 355-362
    • Yuan, L.1    Kuramitsu, Y.2    Li, Y.3    Kobayashi, M.4    Hosokawa, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.